314 related articles for article (PubMed ID: 27939341)
1. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats.
Pittenger ST; Barrett ST; Chou S; Bevins RA
Behav Brain Res; 2017 Mar; 320():195-199. PubMed ID: 27939341
[TBL] [Abstract][Full Text] [Related]
2. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.
Pittenger ST; Barrett ST; Chou S; Bevins RA
Behav Brain Res; 2016 Mar; 300():150-9. PubMed ID: 26638833
[TBL] [Abstract][Full Text] [Related]
3. Nicotine- and cocaine-triggered methamphetamine reinstatement in female and male Sprague-Dawley rats.
Pittenger ST; Chou S; Barrett ST; Catalano I; Lydiatt M; Bevins RA
Pharmacol Biochem Behav; 2017 Aug; 159():69-75. PubMed ID: 28712749
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core.
Everett N; Baracz S; Cornish J
Pharmacol Biochem Behav; 2019 Aug; 183():64-71. PubMed ID: 31202809
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration.
Kufahl PR; Watterson LR; Nemirovsky NE; Hood LE; Villa A; Halstengard C; Zautra N; Olive MF
Neuropharmacology; 2013 Mar; 66():290-301. PubMed ID: 22659409
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.
Baracz SJ; Everett NA; McGregor IS; Cornish JL
Addict Biol; 2016 Mar; 21(2):316-25. PubMed ID: 25399704
[TBL] [Abstract][Full Text] [Related]
7. Female rats display higher methamphetamine-primed reinstatement and c-Fos immunoreactivity than male rats.
Pittenger ST; Chou S; Murawski NJ; Barrett ST; Loh O; Duque JF; Li M; Bevins RA
Pharmacol Biochem Behav; 2021 Feb; 201():173089. PubMed ID: 33422599
[TBL] [Abstract][Full Text] [Related]
8. Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment.
Everett NA; Carey HA; Cornish JL; Baracz SJ
J Psychopharmacol; 2020 Nov; 34(11):1271-1279. PubMed ID: 33081558
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats.
Hay GL; Baracz SJ; Everett NA; Roberts J; Costa PA; Arnold JC; McGregor IS; Cornish JL
J Psychopharmacol; 2018 Dec; 32(12):1369-1378. PubMed ID: 30260267
[TBL] [Abstract][Full Text] [Related]
10. Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats.
Reichel CM; See RE
Int J Neuropsychopharmacol; 2012 Aug; 15(7):919-29. PubMed ID: 21733228
[TBL] [Abstract][Full Text] [Related]
11. The Involvement of Oxytocin in the Subthalamic Nucleus on Relapse to Methamphetamine-Seeking Behaviour.
Baracz SJ; Everett NA; Cornish JL
PLoS One; 2015; 10(8):e0136132. PubMed ID: 26284529
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in methamphetamine seeking in rats: impact of oxytocin.
Cox BM; Young AB; See RE; Reichel CM
Psychoneuroendocrinology; 2013 Oct; 38(10):2343-53. PubMed ID: 23764194
[TBL] [Abstract][Full Text] [Related]
13. The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement.
Everett NA; McGregor IS; Baracz SJ; Cornish JL
Neuropharmacology; 2018 May; 133():1-11. PubMed ID: 29353054
[TBL] [Abstract][Full Text] [Related]
14. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
Pei Y; Asif-Malik A; Hoener M; Canales JJ
Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
[TBL] [Abstract][Full Text] [Related]
15. Transient drug-primed but persistent cue-induced reinstatement of extinguished methamphetamine-seeking behavior in mice.
Yan Y; Yamada K; Nitta A; Nabeshima T
Behav Brain Res; 2007 Feb; 177(2):261-8. PubMed ID: 17182116
[TBL] [Abstract][Full Text] [Related]
16. The effect of chronic oxytocin treatment during abstinence from methamphetamine self-administration on incubation of craving, reinstatement, and anxiety.
Everett NA; Baracz SJ; Cornish JL
Neuropsychopharmacology; 2020 Mar; 45(4):597-605. PubMed ID: 31715618
[TBL] [Abstract][Full Text] [Related]
17. Varenicline impairs extinction and enhances reinstatement across repeated cycles of nicotine self-administration in rats.
Macnamara CL; Holmes NM; Westbrook RF; Clemens KJ
Neuropharmacology; 2016 Jun; 105():463-470. PubMed ID: 26907808
[TBL] [Abstract][Full Text] [Related]
18. Nicotine exposure beginning in adolescence enhances the acquisition of methamphetamine self-administration, but not methamphetamine-primed reinstatement in male rats.
Pipkin JA; Kaplan GJ; Plant CP; Eaton SE; Gil SM; Zavala AR; Crawford CA
Drug Alcohol Depend; 2014 Sep; 142():341-4. PubMed ID: 25042760
[TBL] [Abstract][Full Text] [Related]
19. Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.
Kangiser MM; Dwoskin LP; Zheng G; Crooks PA; Stairs DJ
Behav Pharmacol; 2018 Feb; 29(1):87-97. PubMed ID: 28863003
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats.
Parsegian A; See RE
Neuropsychopharmacology; 2014 Mar; 39(4):811-22. PubMed ID: 23995583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
